<DOC>
	<DOCNO>NCT00288873</DOCNO>
	<brief_summary>Obese person know elevated level parathyroid hormone ( PTH ) low level vitamin D. These hormone important regulation body â€™ calcium store bone health . We would like investigate abnormality accuracy current diagnostic test compare result standard assay vitamin D PTH specific test , obese subject baseline vitamin D replace . We also compare two standard vitamin D replacement regimens determine one effective . This pilot study two part : Part 1 compare level PTH vitamin D use two different assay obese subject normal vitamin D . We plan enroll 20 subject normal vitamin D level 40 subject vitamin D insufficiency . All subject fill questionnaires amount calcium vitamin D diet , recent sunlight exposure . We ask blood sample measure level calcium , vitamin D , albumin , creatinine , glucose , insulin different form PTH . Subjects vitamin D insufficiency randomize receive Vitamin D2 Vitamin D3 standard dos eight week , open label trial . At four eight week , subject fill questionnaires blood test repeat . For safety purpose , urine calcium also monitor .</brief_summary>
	<brief_title>Characterization Hyperparathyroidism Vitamin D Deficiency Obesity</brief_title>
	<detailed_description />
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Hyperparathyroidism</mesh_term>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Hyperparathyroidism , Secondary</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Obese subject body mass index great 40 kg/m2 35 kg/m2 medical condition secondary obesity Willingness take vitamin D supplement If baseline vitamin D level &gt; 25 ng/ml subject eligible control group If baseline vitamin D level &lt; 25 ng/ml subject eligible one two vitamin D replacement group Hypercalcemia Kidney disease Liver disease Malabsorption Prior diagnosis bone disease Medical condition require daily use calcium , antacid , medication know affect bone metabolism interact vitamin D Hypersensitivity formulation vitamin D</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2007</verification_date>
	<keyword>Vitamin D deficiency</keyword>
	<keyword>Secondary hyperparathyroidism</keyword>
	<keyword>Obesity</keyword>
</DOC>